packageVimseltinib

vimseltinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Vimseltinib is a protein kinase inhibitor used to treat giant cell tumour of the tendon sheath. It is an approved anticancer medicine authorised in the European Union.

Summary written by glm-5.3-flash from Wikidata Q106440798 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:vimseltinib
ATC codes:L01EX29
DrugBank:DB17520
PubChem CID:86267612
Wikidata:Q106440798
formula:C23H25N7O2
molar mass:431.5 g/mol (PubChem CID 86267612)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown